...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
【24h】

Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.

机译:抗结核药。第6部分:新型芳基磺酰胺基共轭恶唑烷酮的合成和抗分枝杆菌活性。

获取原文
获取原文并翻译 | 示例
           

摘要

As a part of investigation of new anti-tubercular agents in this laboratory, herein we describe the synthesis of a new class of arylsulfonamido conjugated oxazolidinones. The in vitro activity of these conjugated (6a-f, 7a-d, 9a-c and 11a-c) molecules against Mycobacterium tuberculosis H(37)Rv by using rifampicin and linezolide as positive controls is discussed, compounds 7c and 9a-c are found to be the most active members in this series. Further, cytotoxicity of the potent conjugates of the series (7c, and 9a-c) was evaluated on human foreskin fibroblast (HFF) cells by using MTT assay. Finally, these studies suggest that compounds 7c and 9a may serve as promising lead scaffolds for further generation of new as anti-TB agents.
机译:作为在该实验室中研究新的抗结核药的一部分,我们在此描述了一类新的芳基磺酰胺基共轭恶唑烷酮的合成。通过使用利福平和利奈唑胺作为阳性对照,讨论了这些共轭的(6a-f,7a-d,9a-c和11a-c)分子对结核分枝杆菌H(37)Rv的体外活性,化合物7c和9a-c被发现是该系列中最活跃的成员。此外,通过使用MTT测定法评估了系列(7c和9a-c)的有效缀合物对人包皮成纤维细胞(HFF)的细胞毒性。最后,这些研究表明化合物7c和9a可以用作有前途的铅支架,以进一步产生新的抗结核病药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号